Glucose monitoring in diabetic pregnant women lowers complication risk, study says
26 Sep 2008

Continuous monitoring of glucose as part of antenatal care for women suffering from diabetes improves maternal blood glucose control, lowers birth weight and reduces risk of macrosomia, according to a new study.

Research by staff at Ipswich Hospital in the UK involved 71 women with Type 1 and Type 2 diabetes from antenatal clinics around the country.

They were assigned to standard antenatal care - comprising intermittent self-monitoring of glucose levels using the finger prick technique - or intermittent monitoring plus continual glucose assessment.

Glucose values from subcutaneous tissues were measured electronically every ten seconds, giving up to 288 measurements per day.

"The researchers found that women in the continuous glucose monitoring group had lower mean levels of HbA1c from 32 to 36 weeks' gestation and improved blood glucose control during the third trimester, compared to women receiving standard antenatal care," the study explained.

Babies from mothers who underwent continuous monitoring also had reduced macrosomia risk as well as lower birth weight.

Login and visit the Diabetes Knowledge Centre

Print Article    Bookmark

• Porridge could limit type-2 diabetes side effects 09/01/09
• Men with type-2 diabetes at greater risk of cardiovascular death 06/01/09
• Decline in mental processing affects diabetes patients, study reveals 05/01/09
• Leptin study could lead to new diabetes treatment 23/12/08
• Symptomless virus linked with type 1 diabetes 19/12/08

• PRANDIN Tablets - 49.44%
  ... in patients with Type 2 diabetes (Non Insulin-Dependent Diabetes Mellitus (NIDDM)) whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. Repaglinide is also indicated in combination with metformin in Type 2 diabetes patients who are not ...
  
  
• DDAVP - 49.42%
  ... and treatment of vasopressin-sensitive cranial diabetes insipidus; establishing renal concentration capacity. DDAVP Tablets: Treatment of vasopressin-sensitive cranial diabetes insipidus; treatment of post-hypophysectomy polyuria/ polydipsia. DDAVP/Desmopressin Injection: Cranial diabetes insipidus ...
  
  
• JANUVIA Film-Coated Tablets - 47.95%
  JANUVIA is indicated in patients with type 2 diabetes mellitus to improve glycaemic control in combination with metformin when diet and exercise, plus metformin do not provide adequate glycaemic control. For patients with type 2 diabetes mellitus in whom use of a PPAR? agonist (i.e. a ...
  
  
• EXUBERA - 47.95%
  ... for the treatment of adult patients with type 2 diabetes mellitus not adequately controlled with oral antidiabetic agents and requiring insulin therapy. EXUBERA is also indicated for the treatment of adult patients with type 1 diabetes mellitus, in addition to long or intermediate acting ...
  
  
• NOCUTIL - 47.95%
  Treatment of idiopathic central diabetes insipidus, or diabetes insipidus occurring after hypophysectomy, cranial trauma, or surgery in the pituitary region ...
  
  
• GLUCOPHAGE - 47.95%
  Non-insulin dependent (type II) diabetes either alone or with sulphonylureas. Adjuvant therapy in insulin-dependent diabetes, particularly in the obese ...